Interleukin 1 β suppresses bile acid-induced BSEP expression via a CXCR2-dependent feedback mechanism

PLoS One. 2024 Dec 16;19(12):e0315243. doi: 10.1371/journal.pone.0315243. eCollection 2024.

Abstract

Inflammation-induced cholestasis is a common problem in septic patients and results from cytokine-mediated inhibition of bile acid export including impaired expression of the bile salt export pump (BSEP) with a consecutive increase in intracellular bile acids mediating cell damage. The present study focuses on the mechanisms by which interleukin 1 β (IL-1β), as a critical mediator of sepsis-induced cholestasis, controls the expression of BSEP in hepatocytes. Notably, the treatment of hepatocytes with IL-1β leads to the upregulation of a broad chemokine pattern. Thereby, the IL-1β -induced expression of in particular the CXCR2 ligands CXCL1 and 2 is further enhanced by bile acids, whereas the FXR-mediated upregulation of BSEP induced by bile acids is inhibited by IL-1β. In this context, it is interesting to note that inhibitor studies indicate that IL-1β mediates its inhibitory effects on bile acid-induced expression of BSEP indirectly via CXCR2 ligands. Consistently, inhibition of CXCR2 with the inhibitor SB225002 significantly attenuated of the inhibitory effect of IL-1β on BSEP expression. These data suggest that part of the cholestasis-inducing effect of IL-1β is mediated via a CXCR2-dependent feedback mechanism.

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 11* / genetics
  • ATP Binding Cassette Transporter, Subfamily B, Member 11* / metabolism
  • Animals
  • Bile Acids and Salts* / metabolism
  • Chemokine CXCL1 / genetics
  • Chemokine CXCL1 / metabolism
  • Chemokine CXCL2 / genetics
  • Chemokine CXCL2 / metabolism
  • Cholestasis / metabolism
  • Cholestasis / pathology
  • Feedback, Physiological
  • Hepatocytes* / drug effects
  • Hepatocytes* / metabolism
  • Humans
  • Interleukin-1beta* / metabolism
  • Mice
  • Phenylurea Compounds
  • Receptors, Cytoplasmic and Nuclear / metabolism
  • Receptors, Interleukin-8B* / metabolism

Substances

  • Receptors, Interleukin-8B
  • Interleukin-1beta
  • Bile Acids and Salts
  • ATP Binding Cassette Transporter, Subfamily B, Member 11
  • Chemokine CXCL2
  • Chemokine CXCL1
  • SB 225002
  • farnesoid X-activated receptor
  • Receptors, Cytoplasmic and Nuclear
  • Phenylurea Compounds

Grants and funding

This work was supported by grants from the Deutsche Forschungsgemeinschaft in particular through the collaborative research center SFB 974, project number 190586431 (JGB). Further funding came from projects of the LiSyM Network, project numbers 031L0046 (JGB) as well as the LiSyM cancer Network C-TIP HCC 031L0257G (JGB) funded by the German Federal Ministry of Education and Research. TL was funded from the European Research Council (ERC) through the ERC Consolidator Grant PhaseControl (grant agreement 771083); Deutsche Forschungsgemeinschaft (DFG): 279874820, 461704932, 440603844; the German Cancer Aid (Deutsche Krebshilfe): 70114893; and in part by the Ministry of Culture and Science of the State of North Rhine-Westphalia: NW21-062E (CANTAR), PROFILNRW-2020-107-A (MODS). CA was funded by the Clinician Scientist Program of the Forschungskommission of the medical faculty of the Heinrich-Heine University Düsseldorf.